TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VCYT

Veracyte Inc

Healthcare · Diagnostics & Research

41.50$ +4.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Veracyte Inc (VCYT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 517 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VCYT
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.6 12 22 38 50 65 72 92 120 117 220 297 361 446 517
2.9 7.6 13 17 21 25 28 33 37 41 74 102 113 148 157
-0.3 4.0 9.3 22 28 40 44 59 84 76 145 195 248 298 360
6.7 6.6 7.8 9.8 13 15 14 15 15 17 30 41 57 69 71
5.4 7.9 12 19 23 24 23 24 29 37 101 77 158 178 111
15 23 32 51 61 68 70 81 99 111 227 236 334 282 286
-15 -19 -23 -29 -33 -29 -27 -22 -15 -35 -82 -41 -86 16 74
0.0 0.0 0.2 0.4 0.4 2.8 4.9 2.0 0.7 0.2 0.2 0.2 0.0 0.0 0.0
-14 -19 -26 -29 -34 -31 -31 -23 -13 -35 -82 -36 -77 26 68
0.8 0.0 -2.9 -0.7 0.5 3.0 5.4 1.2 3.9 0.9 -6.1 0.1 -2.2 1.6 1.8
-14 -19 -26 -29 -34 -31 -31 -23 -13 -35 -76 -37 -74 24 66
-14 -18 -24 -29 -33 -25 -24 -17 -7.8 -27 -60 -7.0 -49 49 90

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?